Cantor Fitzgerald’s NEVRO CORP. NVRO Stock Holding History

Cantor Fitzgerald’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-531,204	Closed	-$1.98M	–	410
2024 Q4	$1.98M	Buy	+531,204	New	+$2.45M	0.04%	62

Other funds holding NVRO

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cantor Fitzgerald's NVRO Position: Q1 2025 in Review

Cantor Fitzgerald sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 531,204 shares — an estimated $1.98M sold.

Cantor Fitzgerald first reported a position in NVRO in Q4 2024 and held it in 1 quarter. The position peaked at $1.98M in Q4 2024. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

Cantor Fitzgerald reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
Cantor Fitzgerald sold 531,204 NEVRO CORP. shares in Q1 2025, an estimated $1.98M.
Cantor Fitzgerald first reported a position in NEVRO CORP. in Q4 2024 and held it in 1 quarter.
Cantor Fitzgerald's NEVRO CORP. position peaked at $1.98M in Q4 2024.
126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Cantor Fitzgerald's 13F filing for Q1 2025, filed 15 May 2025.